These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10945196)

  • 1. Assistance programs available for medications commonly used in transplant patients.
    Chisholm MA; Tackett KL; Kendrick BD; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):269-81. PubMed ID: 10945196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical manufacturer assistance programs.
    Chisholm MA; DiPiro JT
    Arch Intern Med; 2002 Apr; 162(7):780-4. PubMed ID: 11926851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.
    Chisholm MA; Vollenweider LJ; Mulloy LL; Wynn JJ; Wade WE; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):304-7. PubMed ID: 10945200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing medication access to transplant recipients.
    Chisholm M
    Clin Transplant; 2004 Feb; 18(1):39-48. PubMed ID: 15108769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication assistance programs for uninsured and indigent patients.
    Chisholm MA; Reinhardt BO; Vollenweider LJ; Kendrick BD; DiPiro JT
    Am J Health Syst Pharm; 2000 Jun; 57(12):1131-6. PubMed ID: 10911511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S13-7. PubMed ID: 17057055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital's experience.
    Viale PH; Mister S
    Clin J Oncol Nurs; 2001; 5(6):247-52. PubMed ID: 11899624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the evidence for pharmaceutical patient assistance programs? A systematic review.
    Felder TM; Palmer NR; Lal LS; Mullen PD
    J Health Care Poor Underserved; 2011 Feb; 22(1):24-49. PubMed ID: 21317504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current therapeutics 2000].
    Scheen AJ
    Rev Med Liege; 2000 Sep; 55(9):852-61. PubMed ID: 11105601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus.
    Strum MW; Hopkins R; West DS; Harris BN
    Am J Health Syst Pharm; 2005 May; 62(10):1048-52. PubMed ID: 15901589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding risk evaluation and mitigation strategies in organ transplantation.
    Gabardi S
    Pharmacotherapy; 2011 Jul; 31(7):714-22. PubMed ID: 21923459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication nonadherence and its relation to financial restriction.
    Paris W; Dunham S; Sebastian A; Jacobs C; Nour B
    J Transpl Coord; 1999 Sep; 9(3):149-52. PubMed ID: 10703398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessing patient assistance programs to meet clients' medication needs.
    Williams K
    J Am Acad Nurse Pract; 2000 Jun; 12(6):233-5. PubMed ID: 11930446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transparency of Industry-Sponsored Oncology Patient Financial Assistance Programs Using a Patient-Centered Approach.
    Zafar SY; Peppercorn J; Asabere A; Bastian A
    J Oncol Pract; 2017 Mar; 13(3):e240-e248. PubMed ID: 28140745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy assistance programs in a community health center setting.
    Torres MC; Herman D; Montano S; Love L
    J Natl Med Assoc; 2002 Dec; 94(12):1077-86. PubMed ID: 12510707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals.
    Trompeter JM; Havrda DE
    Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription assistance programs: options for assisting the uninsured and underinsured.
    Turowski RC; Raskay-Bianco MM; Visconti JA
    Hosp Pharm; 1993 Oct; 28(10):948, 951-5, 958-68. PubMed ID: 10129140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA; Melroy J; Johnson M; Mulloy LL; Spivey CA
    J Am Geriatr Soc; 2007 Mar; 55(3):389-94. PubMed ID: 17341241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.